SciELO - Scientific Electronic Library Online

 
vol.48 número2Curso clínico y frecuencia de factores de riesgo asociados a mortalidad por SDRA por COVID-19 en UCI índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Medica Colombiana

versión impresa ISSN 0120-2448

Resumen

AGUILAR-MOLINA, OSWALDO ENRIQUE et al. Clinical pregnancy outcomes in women with mechanical prosthetic valves. Acta Med Colomb [online]. 2023, vol.48, n.2, e1.  Epub 01-Abr-2024. ISSN 0120-2448.  https://doi.org/10.36104/amc.2023.2720.

Introduction:

Pregnant women with mechanical prosthetic valves (MPVs) have a higher risk of complications. We set out to identify and describe the main complications of pregnant women with MPVs, whether these are preventable, and their impact on cardiovascular, obstetric and fetal outcomes.

Materials and methods:

An analytical, observational study of a prospective cohort at a cardiac-obstetric clinic. The registry began in January 2016 and continues to date. This study reports the main cardiovascular, fetal and obstetric outcomes in pregnant women with MVPs included in the registry up to November 2021. We evaluated maternal, cardiac, obstetric, neonatal and safety outcomes.

Results:

From January 1, 2016, to November 1, 2021, 22 patients with a mechanical prosthetic valve who underwent 22 pregnancies were included in the REMEC. The mean age was 26.5 years (IQR 14-40). The median CARPREG II was 6 points, 86% were classified as mWHO class III and 14% were in class IV; 72.7% (16) had inadequate anticoagulation on admission, 18.1% (4) were not on any anticoagulant on admission, 40.9% (9) used VKAs and 40.9% (9) were on low molecular weight heparin. There was a 100% survival rate during follow up; however, the rate of complications was high. We found only four women (18%) with no obstetric or neonatal primary or secondary cardiac outcome. Primary cardiac events occurred in 18.1% of the patients, secondary cardiac events in 13%, obstetric outcomes in three (13.6%) and neonatal events in 45.4% (10). Fifty-nine percent of the patients had late evaluations. We found mechanical valve thrombosis in 36.3%.

Conclusions:

In our experience, although all the pregnant women survived, the rate of complications was high, with a higher proportion of neonatal complications. We found a high percentage of late evaluation, inadequate anticoagulation and preventable events. (Acta Med Colomb 2022; 48. DOI:https://doi.org/10.36104/amc.2023.2720).

Palabras clave : pregnancy; valve disease; prosthetic valve thrombosis.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )